Will This New GLP-1 Drug be More Powerful Than Ozempic?
Investors seek answers on Novo Nordisk’s next-gen obesity drug, CagriSema.
Read more at Inc.
Topics
-
Regeneron’s earnings boosted by more than doubling of U.S. sales of blockbuster eye drug Eylea
Regeneron Pharmaceuticals Inc.’s stock rose 4.9% Tuesday to put it on track for its biggest one-day gain in almost two years, after the company posted better-than-expected fourth-quarter earnings, ...MarketWatch - 1h -
More than 140,000 homes still without power after Storm Éowyn
It could take up to 10 days for power to be restored to all of the affected properties, according to NIE.BBC News - Jan. 25 -
Ozempic maker’s stock surges. A trial of a new Novo Nordisk drug shows promise.
Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%.MarketWatch - Jan. 24 -
Ford recalls more than 270,000 Broncos and Mavericks due to loss of power problem
Ford Motor Co. is recalling more than 270,000 Broncos and Mavericks due to a power problem that can cause vehicles to stop unexpectedly or fail to startABC News - Jan. 24 -
Obesity drugs Ozempic and Wegovy included in US price-cut talks
Novo Nordisk shares hit as government adds blockbuster weight-loss treatments to new round of negotiationsFinancial Times - Jan. 17 -
Ozempic Among the Next Drugs Up for Medicare Price Negotiations
The list of drugs account for $41 billion in annual Medicare spending, the Biden administration said.The Wall Street Journal - Jan. 17 -
Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.NBC News - Jan. 17 -
Ozempic, Wegovy on list for Medicare drug price negotiations
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.CBS News - Jan. 17 -
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.NBC News - Jan. 9
More from Inc.
-
Is Klarna’s Vaunted AI Job Elimination Claim Really Pre-IPO Marketing?
CEO Sebastian Siemiatkowski said the fintech company stopped hiring in 2023 as AI apps replaced employees, but evidence suggests things might not be quite so dire for human employees.Inc. - 25m -
In Wider Restructuring Plan, Estee Lauder to Cut 7,000 Jobs
Global sales dips prompt new CEO to expand the scope of a turnaround effort with additional layoffs.Inc. - 51m -
NHL Players’ Association and Professional Hockey Players’ Association Join the AFL-CIO
In the two years since it added a sports council, the labor federation has added unions representing payers in the NFL, WNBA, Major League Soccer and National Women’s Soccer League.Inc. - 1h -
Here’s How OpenAI’s New Deep Research Tool Could Change Your Workplace
ChatGPT can now write complex reports and cite its sources. That could free up your workers and change how you task them dramatically.Inc. - 1h -
Elon Musk Sows Confusion By Saying He ‘Deleted’ IRS Direct File Program
The free filing program from the IRS remains available for the coming tax season.Inc. - 1h
More in Business
-
Apollo chief predicts wave of asset partnerships will shake up Wall Street
Marc Rowan says his firm could create co-branded investment funds with traditional managersFinancial Times - 9m -
Estée Lauder is trying to fast-track premium products. But it’s cutting jobs, and is the S&P 500’s worst performer today.
Estée Lauder on Tuesday announced plans to cut thousands of jobs and speed up its product development to reclaim relevance in higher-end beauty, after the company swung to a quarterly loss and ...MarketWatch - 18m -
PepsiCo Adding Healthier Snacks as Its North American Sales Dip
Rising consumer demand for fewer empty calories is pushing the snack and beverage giant to offer options with less sodium, fat and artificial ingredients.The New York Times - 24m -
Is Klarna’s Vaunted AI Job Elimination Claim Really Pre-IPO Marketing?
CEO Sebastian Siemiatkowski said the fintech company stopped hiring in 2023 as AI apps replaced employees, but evidence suggests things might not be quite so dire for human employees.Inc. - 25m -
Amazon to face legal action after Quebec warehouse closures trigger mass layoffs
A union that represents some Montreal Amazon workers said it will petition a court to compel the company to reopen the warehouses and reverse the job cuts.CNBC - 28m